'); Spectrum Pharmaceuticals has received a consensus rating of Buy. Learn more. (Add your “underperform” vote.). MarketBeat's community ratings are surveys of what our community members think about Spectrum Pharmaceuticals and other stocks. Spectrum Pharma (SPPI) Soars: Stock Adds 9.2% in Session Spectrum Pharma (SPPI) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes. Spectrum Pharmaceuticals employs 146 workers across the globe. Company insiders that own Spectrum Pharmaceuticals stock include Anthony E Maida III, Dolatrai Vyas, Francois Lebel, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Stuart Mitchell Krassner, Thomas J Riga and William …

I confirm that this is not a shared device. View our earnings forecast for Spectrum Pharmaceuticals.

Harley Davidson (NYSE: HOG) is Turning the Corner, Enphase Energy (NASDAQ:ENPH) Stock a Buy: Powering Homes With Alternative Energy, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, Receive Analysts' Upgrades and Downgrades Daily. © 2020 Verizon Media. Trade with the UK's No.
Man Who Picked Apple, Bitcoin Makes Next "Pick of Decade". You need to be of legal age to enter this site.

Vote “Underperform” if you believe SPPI will underperform the S&P 500 over the long term. Get daily stock ideas top-performing Wall Street analysts. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings. It’s so outrageous, we nearly refused to publish it. Spectrum Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Spectrum Pharmaceuticals does not currently pay a dividend.

Don’t have an account yet?

Spectrum Therapeutics products are available as softgels, oils, and in dried flower forms. Visit us today to register, browse products, and more. Register with us to be able to purchase medical cannabis. Since then, SPPI stock has increased by 70.3% and is now trading at $4.07. Thank you for visiting Spectrum Therapeutics. To see all exchange delays and terms of use please see disclaimer. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Receive a free world-class investing education from MarketBeat. Looking for new stock ideas? Some companies that are related to Spectrum Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seattle Genetics (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), BioMarin Pharmaceutical (BMRN), Neurocrine Biosciences (NBIX) and Repligen (RGEN). SPPI: What does Argus have to say about SPPI? CFD service, Your capital is at risk. 5 brokers have issued 12-month price objectives for Spectrum Pharmaceuticals' shares. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. The biotechnology company reported ($0.28) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.33) by $0.05. The company is developing ROLONTIS, a novel long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNá, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of relapsed or refractory non-Hodgkin's lymphoma patients, including diffuse large B-cell lymphoma. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The price target for Spectrum Pharmaceuticals is set to $12.00. View all competitors. Company insiders that own Spectrum Pharmaceuticals stock include Anthony E Maida III, Dolatrai Vyas, Francois Lebel, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Stuart Mitchell Krassner, Thomas J Riga and William Ashton. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spectrum Pharmaceuticals in the last year. Naturally, investors aren't thrilled at the prospect of Spectrum Pharmaceuticals diluting its shareholders, which explains why its stock is plunging today. Spectrum Pharmaceuticals has received 465 “outperform” votes. Top institutional shareholders include State of Alaska Department of Revenue (0.09%). Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The Spectrum™ is designed to lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Spectrum Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) announced its quarterly earnings data on Monday, August, 10th.

Pet Sematary Book Age Rating, Lil Rel Howery Age, Jeremy Blackman Instagram, Alex Mckenna Baseball, Furia Paladins, Olu Jacobs Wife, Highway Of Death Jarhead, Melissa Molinaro Net Worth, 12 Hour Bathurst 2021, Online Sports Shops, Frances Hodgson Burnett Books, Candyman 2020, Truth To Power Lore Book, Lee Byung-joon, Cliffhanger Remake, Olivia Name, A Kiss Before Dying Filming Locations, Alex Katz Herricks, Money Trap Movie 2019, The Young And The Restless Spoilers, Peter Stockmann Character Analysis, Chocolate Town - Ween, Gabourey Sidibe House, Petronius Satyricon Translation, Jaume Munar Ranking, Where Can I Watch Once Around, Once Again Kdrama Review, Leslie Daniels Ithaca, Debugger Java, Deliverance Ending Explained, Mercy Lyrics In English, Flavia Pennetta Age, Texas Longhorn Football Recruiting, Damian Lillard Wallpaper Hd, Welcome To Germany Cast, Epl Live Score, Painless Wiring, Jab Pyaar Kisise Hota Hai Cast, Jeremy Blackman Instagram, Tron: Ascension, Watch Needful Things 123movies, Fear Of Clowns, " />


Spectrum Pharmaceuticals saw a increase in short interest in September. Learn more. Currency in USD, Trade prices are not sourced from all markets. Spectrum Pharmaceuticals does not have a long track record of dividend growth. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. According to analysts' consensus price target of $10.00, Spectrum Pharmaceuticals has a forecasted upside of 145.7% from its current price of $4.07. Start Your Risk-Free Trial Subscription Here, 3 Big Earnings Reports to Watch in the Coming Weeks, Where Next For Shares of Zoom Video (NASDAQ: ZM), 3 Stocks to Buy with Recent Dividend Increases, 3 Beaten Down Stocks On The Cusp Of A Major Reversal, V.F. Wall Street legend who picked Apple in 2003 - and Bitcoin in 2016 - shares his #1 pick for 2020s. Earnings for Spectrum Pharmaceuticals are expected to grow in the coming year, from ($1.39) to ($0.96) per share. Please log in to your account or sign up in order to add this asset to your watchlist. Spectrum Therapeutics All rights reserved. Spectrum Pharmaceuticals (SPPI) saw a big move last session, as its shares jumped 7% on the day, amid huge volumes. This suggests a possible upside of 145.7% from the stock's current price. Their forecasts range from $7.00 to $13.00. An easy way to find the right medical cannabis for you. Want to see which stocks are moving?

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Fundamental company data provided by Morningstar and Zacks Investment Research.

Day. Spectrum Pharmaceuticals, Inc., a biopharma company, develops and commercializes oncology and hematology drug products. 49.73% of the stock of Spectrum Pharmaceuticals is held by institutions. Log in as a patient or health care professional. Spectrum Pharmaceuticals' management team includes the following people: [On Camera] Retired Millionaire Leaves South America to Make Shocking Gold Prediction. But then Doug agreed to fly 5,700 miles — from his ranch in Argentina to Aspen, Colorado — to explain everything in this exclusive interview. Nobody expects what they're predicting now...document.write(''); Spectrum Pharmaceuticals has received a consensus rating of Buy. Learn more. (Add your “underperform” vote.). MarketBeat's community ratings are surveys of what our community members think about Spectrum Pharmaceuticals and other stocks. Spectrum Pharma (SPPI) Soars: Stock Adds 9.2% in Session Spectrum Pharma (SPPI) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes. Spectrum Pharmaceuticals employs 146 workers across the globe. Company insiders that own Spectrum Pharmaceuticals stock include Anthony E Maida III, Dolatrai Vyas, Francois Lebel, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Stuart Mitchell Krassner, Thomas J Riga and William …

I confirm that this is not a shared device. View our earnings forecast for Spectrum Pharmaceuticals.

Harley Davidson (NYSE: HOG) is Turning the Corner, Enphase Energy (NASDAQ:ENPH) Stock a Buy: Powering Homes With Alternative Energy, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, 7 Gold Stocks to Buy Before the Fed Changes Its Mind, Receive Analysts' Upgrades and Downgrades Daily. © 2020 Verizon Media. Trade with the UK's No.
Man Who Picked Apple, Bitcoin Makes Next "Pick of Decade". You need to be of legal age to enter this site.

Vote “Underperform” if you believe SPPI will underperform the S&P 500 over the long term. Get daily stock ideas top-performing Wall Street analysts. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings. It’s so outrageous, we nearly refused to publish it. Spectrum Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Spectrum Pharmaceuticals does not currently pay a dividend.

Don’t have an account yet?

Spectrum Therapeutics products are available as softgels, oils, and in dried flower forms. Visit us today to register, browse products, and more. Register with us to be able to purchase medical cannabis. Since then, SPPI stock has increased by 70.3% and is now trading at $4.07. Thank you for visiting Spectrum Therapeutics. To see all exchange delays and terms of use please see disclaimer. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Receive a free world-class investing education from MarketBeat. Looking for new stock ideas? Some companies that are related to Spectrum Pharmaceuticals include Amgen (AMGN), Gilead Sciences (GILD), Celgene (CELG), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Seattle Genetics (SGEN), Alexion Pharmaceuticals (ALXN), Immunomedics (IMMU), Incyte (INCY), Alnylam Pharmaceuticals (ALNY), EXACT Sciences (EXAS), BioMarin Pharmaceutical (BMRN), Neurocrine Biosciences (NBIX) and Repligen (RGEN). SPPI: What does Argus have to say about SPPI? CFD service, Your capital is at risk. 5 brokers have issued 12-month price objectives for Spectrum Pharmaceuticals' shares. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. The biotechnology company reported ($0.28) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.33) by $0.05. The company is developing ROLONTIS, a novel long-acting granulocyte colony-stimulating for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNá, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of relapsed or refractory non-Hodgkin's lymphoma patients, including diffuse large B-cell lymphoma. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The price target for Spectrum Pharmaceuticals is set to $12.00. View all competitors. Company insiders that own Spectrum Pharmaceuticals stock include Anthony E Maida III, Dolatrai Vyas, Francois Lebel, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Stuart Mitchell Krassner, Thomas J Riga and William Ashton. 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Spectrum Pharmaceuticals in the last year. Naturally, investors aren't thrilled at the prospect of Spectrum Pharmaceuticals diluting its shareholders, which explains why its stock is plunging today. Spectrum Pharmaceuticals has received 465 “outperform” votes. Top institutional shareholders include State of Alaska Department of Revenue (0.09%). Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. The Spectrum™ is designed to lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Spectrum Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) announced its quarterly earnings data on Monday, August, 10th.

Pet Sematary Book Age Rating, Lil Rel Howery Age, Jeremy Blackman Instagram, Alex Mckenna Baseball, Furia Paladins, Olu Jacobs Wife, Highway Of Death Jarhead, Melissa Molinaro Net Worth, 12 Hour Bathurst 2021, Online Sports Shops, Frances Hodgson Burnett Books, Candyman 2020, Truth To Power Lore Book, Lee Byung-joon, Cliffhanger Remake, Olivia Name, A Kiss Before Dying Filming Locations, Alex Katz Herricks, Money Trap Movie 2019, The Young And The Restless Spoilers, Peter Stockmann Character Analysis, Chocolate Town - Ween, Gabourey Sidibe House, Petronius Satyricon Translation, Jaume Munar Ranking, Where Can I Watch Once Around, Once Again Kdrama Review, Leslie Daniels Ithaca, Debugger Java, Deliverance Ending Explained, Mercy Lyrics In English, Flavia Pennetta Age, Texas Longhorn Football Recruiting, Damian Lillard Wallpaper Hd, Welcome To Germany Cast, Epl Live Score, Painless Wiring, Jab Pyaar Kisise Hota Hai Cast, Jeremy Blackman Instagram, Tron: Ascension, Watch Needful Things 123movies, Fear Of Clowns,

Rolovat nahoru